Content Menu
Baird Conferences > Global Healthcare Conference - 2021 > Agenda

Global Healthcare Conference - 2021 - Agenda

September 14 - 15, 2021
VIRTUAL CONFERENCE
Hosted in Eastern Time (EDT)

PARTICIPATING COMPANIES
The following agenda outlines the specific day and time each of the participating companies will present at the conference. Select a particular day to find a list of presenting companies. You can either scroll down the page or select a specific day in which you are most interested. By selecting a company name, you can review a brief description of that company.

If you have any questions, please contact Baird Conferences & IES at bairdconferences@rwbaird.com or call (414) 765-7056.

This agenda is subject to change and was updated as of 08/26/2021.
PRINTER FRIENDLY AGENDA
Presentations for Tuesday, September 14, 2021
08:30 AM - 09:00 AM
Medpace Holdings, Inc.
Session I
Medpace is a leading clinical contract research organization (CRO). The company provides Phase I-IV development and central laboratory services.

Ticker
MEDP

Guest Speakers
Jesse Geiger, President
Kevin Brady, CFO
Lauren Morris, Associate Director, IR

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$6,487 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
Syndax Pharmaceuticals, Inc.
Session II
Syndax Pharmaceuticals, Inc. is a mid-stage clinical biopharma company, with lead programs SNDX-5613 in acute leukemias and axatilimab in 3L cGVHD.

Ticker
SNDX

Guest Speakers
Briggs Morrison, CEO
Michael Metzger, President & COO
Daphne Karydas, CFO
Anjali Ganguli, VP, Corporate Development

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$804 (updated 07/13/2021)

Industry
Biotechnology
Sio Gene Therapies, Inc.
Session III
Sio is a New York-based biopharmaceutical company that focuses on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.

Ticker
SIOX

Guest Speakers
Pavan Cheruvu, CEO

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$177 (updated 07/13/2021)

Industry
Biotechnology
Mersana Therapeutics, Inc.
Session IV
Mersana Therapeutics is a Cambridge, MA-based clinical-stage biotech company focused on the development of novel antibody drug conjugates for the treatment of cancer.

Ticker
MRSN

Guest Speakers
Anna Protopapas, President & CEO
Brian DeSchuytner, SVP, Finance & Product Strategy
Tim Lowinger, Chief Science & Technology Officer
Arvin Yang, Chief Medical Officer
Sarah Carmody, Executive Director, IR & Corporate Communications
James Salierno, Associate Director, IR

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$902 (updated 07/13/2021)

Industry
Biotechnology
09:05 AM - 09:35 AM
Nyxoah SA
Session II
Nyxoah is developing an externally powered implantable neurostimulation system for obstructive sleep apnea. The Genio system has CE Mark but is not yet FDA approved.

Ticker
NYXH

Guest Speakers
Oliver Taelman, CEO
Fabian Suarez, CFO
Vivian Cervantes, IR
Sam Bentzinger, IR
Laine Morgan, IR

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$765 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Centogene N.V.
Session III
Centogene N.V. is commercial-stage company utilizing clinical and genetic data to develop orphan drugs in order to improve the diagnosis and treatment of rare diseases.

Ticker
CNTG

Guest Speakers
Andrin Oswald, CEO
Rene Just, CFO

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$247 (updated 07/13/2021)

Industry
Biotechnology
Bicara Therapeutics, Inc.*
Session IV
Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of immunotherapy.

Ticker
PRIVATE

Guest Speakers
Claire Mazumdar, CEO
Ivan Hyep, CFO

Industry
Biotechnology
Sharecare, Inc.
Session I
Sharecare, Inc. provides an online health and wellness engagement platform that provides consumers with a personal results-oriented experience by connecting them to health resources and programs.

Ticker
SHCR

Guest Speakers
Jeff Arnold, Founder & CEO
Justin Ferrero, CFO

Industry
Health Care Technology
09:40 AM - 10:10 AM
Colfax Corporation
Session I
Colfax is a leading industrial manufacturer of fabrication/welding and orthopedic reconstructive/rehabilitation products.

Ticker
CFX

Guest Speakers
Matt Trerotola, President & CEO
Mike Macek, VP, Finance

Analyst
Michael Halloran, CFA
mhalloran@rwbaird.com
414.298.1964

Market Cap (in millions)
$6,195 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Strata Oncology, Inc.*
Session II
Strata Oncology, Inc. is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer. The company combines molecular profiling, real-world data, and a large-scale clinical trial platform to identify and deliver optimal treatments for patients with cancer. StrataNGS is a comprehensive genomic profiling test that features the lowest tumor tissue requirements in the industry so that more patients can get the results and treatments they need.

Ticker
Private

Guest Speakers
Dan Rhodes, CEO

Industry
Life Sciences Tools & Services
Albireo Pharma, Inc.
Session III
Albireo Pharma, Inc. is a clinical-stage biopharmaceutical company based in Boston, MA focused on developing odevixibat, as a treatment for pediatric cholestatic liver diseases.

Ticker
ALBO

Guest Speakers
Ron Cooper, President & CEO
Simon Harford, CFO

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$683 (updated 07/13/2021)

Industry
Biotechnology
Exicure, Inc.
Session IV
Exicure, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for immuno-oncology, genetic disorders and other indications based on its Spherical Nucleic Acid (SNA) technology.

Ticker
XCUR

Guest Speakers
David Giljohann, CEO
Brian Bock, CFO

Market Cap (in millions)
$125 (updated 07/27/2021)

Industry
Biotechnology
10:15 AM - 10:45 AM
Charles River Laboratories International, Inc.
Session I
CRL's portfolio includes: laboratory research animals, a leading nonclinical CRO, and quality control solutions for drug manufacturing.

Ticker
CRL

Guest Speakers
James Foster, Chairman, President & CEO
Todd Spencer, VP, IR

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$18,968 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
Sotera Health Company
Session II
Sotera Health Company is a leading provider of terminal sterilization services, cobalt-60 finished sources, and microbiological and analytical chemistry laboratory testing services.

Ticker
SHC

Guest Speakers
Scott Leffler, CFO
Jason Peterson, Senior Director & Treasurer
Sally Curley, External IR Consultant
Jenny Kobin, External IR Consultant

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$6,840 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
US Medical Innovations, LLC*
Session III
US Medical Innovations, LLC (USMI), based in Takoma Park, MD, is a privately held FDA-registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.

Ticker
Private

Guest Speakers
Jerome Canady, M.D., CEO
Paul Sandock, VP, Business Development & Marketing
David Hinds, VP, Product Commercialization
Kenniah Chestnut, VP, Legal Affairs
Xiaoqian Cheng, Phd, Director Plasma Technology
Taisen Zhuang, PhD, CTO & COO
Doug Jones, VP Sales
Saravana Murthy, PhD, Director, Plasma Immunology
Drew Patrick, Director, Communications

Industry
Healthcare Equipment & Supplies
Intercept Pharmaceuticals, Inc.
Session IV
Intercept Pharmaceuticals is a New York City-based biopharmaceutical company dedicated to the development of therapeutics to treat various liver diseases and metabolic disorders.

Ticker
ICPT

Guest Speakers
Jerry Durso, President, CEO
Andrew Saik, CFO
Michelle Berrey, President R&D, Chief Medical Officer
Lisa Defrancesco, SVP, Corporate Affairs & IR

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$541 (updated 08/02/2021)

Industry
Biotechnology
10:50 AM - 11:20 AM
Zimmer Biomet Holdings, Inc.
Session I
Zimmer Biomet is a leader in the ~$37B global orthopedic market with a ~35-40% share of the ~$13B ww hip/knee market.

Ticker
ZBH

Guest Speakers
Bryan Hanson, Chairman, President & CEO
Suky Upadhyay, EVP & CFO
Keri Mattox, SVP, IR & Chief Communications Officer
Pradipto Bagchi, VP, Treasurer
Ezgi Yagci, IR Manager
Margurite Rosania, Project Manager
David Salmon, IR Analyst

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$33,937 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Signify Health, Inc.
Session II
SGFY is a technology-enabled provider of Home & Community services and Episodes of Care services.

Ticker
SGFY

Guest Speakers
Kyle Armbrester, CEO
Steve Senneff, President & CFO
Jennifer DiBerardino, Head of IR & Treasurer

Analyst
Vikram Kesavabhotla
vkesavabhotla@rwbaird.com
646.557.2727

Market Cap (in millions)
$6,724 (updated 07/13/2021)

Industry
Health Care Providers & Services
Orum Therapeutics, Inc.*
Session III
Orum Therapeutics is pioneering the development of tumor-directed targeted protein degraders to improve the treatment of cancer. The company�s neoDegraders are novel, proprietary payloads for targeted protein degradation and its Antibody neoDegrader Conjugate (AnDC) platform generates first-in-class antibody drug conjugates. The first therapeutic candidates from the AnDC platform are in development for the treatment of solid tumors and hematologic cancers. Orum is located in Cambridge, Massachusetts, U.S., and Daejeon, Korea.

Ticker
Private

Guest Speakers
SJ Lee, CEO
Jae Won Kim, CFO

Industry
Biotechnology
PerkinElmer, Inc.
Session IV
PerkinElmer, Inc. provides products and systems to life sciences research, medical, and other markets through its two business verticals, Discovery & Analytical Solutions and Diagnostics.

Ticker
PKI

Guest Speakers
Steve Willoughby, VP, IR

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$19,345 (updated 07/29/2021)

Industry
Life Sciences Tools & Services
11:25 AM - 11:55 AM
Inspire Medical Systems, Inc.
Session II
Inspire sells a first-in-class, FDA-approved neurostimulation system for patients with obstructive sleep apnea that have failed positive airway pressure treatments like CPAP.

Ticker
INSP

Guest Speakers
Timothy Herbert, President & CEO
Richard Buchholz, CFO

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$5,075 (updated 07/13/2021)

Industry
Health Care Technology
Metabolon, Inc.*
Session III
Metabolon,Inc. is the global leader in metabolomics, with a mission to deliver metabolomics data and insights that expand and accelerate the impact of life sciences research in all its applications.

Ticker
Private

Guest Speakers
Rohan Hastie, President & CEO
John Kurtzweil, CFO
Karl Bradshaw, Head of Corporate Development

Industry
Life Sciences Tools & Services
Gamida Cell Ltd.
Session IV
Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases.

Ticker
GMDA

Guest Speakers
Julian Adams, CEO
Michele Korfin, Chief Operating & Chief Commercial Officer
Josh Hamermesh, Chief Business Officer

Market Cap (in millions)
$323 (updated 07/23/2021)

Industry
Biotechnology
Owens & Minor, Inc.
Session I
OMI is a leading healthcare logistics company that serves provider and manufacturer customers in the U.S. and Europe.

Ticker
OMI

Guest Speakers
Edward Pesicka, President & CEO
Andrew Long, EVP & CFO
Jonathan Leon, SVP, Treasurer
Chandrika Nigam, Director, IR

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$3,125 (updated 07/13/2021)

Industry
Health Care Providers & Services
12:15 PM - 12:45 PM
Masimo Corporation
Session II
Masimo is a global leader in pulse oximetry and has a growing portfolio of connectivity and other noninvasive patient monitoring solutions.

Ticker
MASI

Guest Speakers
Micah Young, CFO
Mike Lazinski, SVP, Finance
Eli Kammerman, VP, Business Development & IR

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$14,149 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Enanta Pharmaceuticals, Inc.
Session III
Enanta is a biotech company that uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

Ticker
ENTA

Guest Speakers
Jay R. Luly, Ph.D., President, CEO & Director
Paul Mellett, CFO
Tara Kieffer, SVP, New Product Strategy & Development
Jennifer Viera, Senior Director, IR

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$883 (updated 07/13/2021)

Industry
Biotechnology
BioMarin Pharmaceutical Inc.
Session IV
BioMarin Pharmaceutical is a commercial-stage biotech company focused on rare diseases with a robust late-stage pipeline.

Ticker
BMRN

Guest Speakers
JJ Bienaime, Chairman & CEO
Brian Mueller, EVP & CFO

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$14,563 (updated 07/20/2021)

Industry
Biotechnology
IQVIA Holdings, Inc.
Session I
IQVIA provides information, analytics, software, and service solutions to life science customers globally. The enterprise includes the largest contract research organization or CRO.

Ticker
IQV

Guest Speakers
Ron Bruehlman, EVP & CFO
Nick Childs, SVP, IR & Corporate Communications

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$48,097 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
12:50 PM - 01:20 PM
Maravai LifeSciences Holdings, Inc.
Session I
MRVI is a commercial-stage life sciences company that provides products for the development of therapeutics, vaccines, and diagnostics, from early R&D through potential commercialization.

Ticker
MRVI

Guest Speakers
Kevin Herde, CFO
Deb Hart, Head of IR

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$10,906 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
SAb Biotherapeutics, Inc.
Session II
SAB Biotherapeutics, Inc. (SAB) is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies based on its human polyclonal antibodies.

Ticker
Proposed: SABB

Guest Speakers
Eddie Sullivan, CEO
Tim Cunningham, CFO
Melissa Ullerich, Chief Corporate Communications & IR Officer

Industry
Biotechnology
Mirum Pharmaceuticals, Inc.
Session IV
Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Foster City, CA focused on developing maralixibat, as a treatment for pediatric cholestatic liver diseases.

Ticker
MIRM

Guest Speakers
Chris Peetz, President & CEO
Ian Clements, CFO

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$408 (updated 07/22/2021)

Industry
Biotechnology
Henry Schein, Inc.
Session III
HSIC is the largest distributor of healthcare products and services to office-based practitioners in North America and Europe.

Ticker
HSIC

Guest Speakers
Stanley Bergman, Chairman of the Board & CEO
Steven Paladino, EVP, CFO

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$10,699 (updated 07/13/2021)

Industry
Health Care Providers & Services
01:25 PM - 01:55 PM
AdaptHealth Corp.
Session I
AdaptHealth is a leading US provider of home medical equipment and supplies.

Ticker
AHCO

Guest Speakers
Steve Griggs, CEO
Josh Parnes, President
Jason Clemens, CFO

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$3,545 (updated 07/13/2021)

Industry
Health Care Providers & Services
Vocera Communications, Inc.
Session II
Vocera is a leading provider of clinical communications and workflow solutions to healthcare and non-healthcare facilities in the US and abroad.

Ticker
VCRA

Guest Speakers
Steve Anheier, CFO
Susan Dooley, VP, IR

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$1,389 (updated 07/13/2021)

Industry
Health Care Technology
Applied Therapeutics Inc.
Session III
Applied Therapeutics is a clinical stage biotech company focused on developing aldose reductase inhibitors for the treatment of sorbitol-related indications.

Ticker
APLT

Guest Speakers
Shoshana Shendelman, CEO & Founder
Chuck Silberstein, CFO
Adam Hansard, Chief Commercial Officer

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$553 (updated 07/13/2021)

Industry
Biotechnology
AMN Healthcare Services, Inc.
Session IV
AMN is the largest provider of healthcare staffing services and workforce solutions in the United States.

Ticker
AMN

Guest Speakers
Susan Salka, President & CEO
Chris Schwartz, Controller
Santhi Gullapalli, VP, Finance
Randy Reece, Director, IR & Strategy

Analyst
Mark S. Marcon, CFA
mmarcon@rwbaird.com
414.298.7556

Market Cap (in millions)
$4,747 (updated 07/29/2021)

Industry
Health Care Providers & Services
02:00 PM - 02:30 PM
Bio-Techne Corporation
Session I
Bio-Techne Corporation is a leading producer of proteins, antibodies, immunoassays, and other reagents/kits and also manufactures clinical diagnostic controls and protein analysis tools.

Ticker
TECH

Guest Speakers
David Clair, Senior Director, IR & Corporate Development

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$17,714 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
Invacare Corporation
Session II
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide.

Ticker
IVC

Guest Speakers
Matt Monaghan, Chairman, President & CEO
Kathy Leneghan, SVP & CFO
Lois Lee, Director, Treasury, IR & Corporate Communications

Market Cap (in millions)
$293 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Geron Corporation
Session III
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Ticker
GERN

Guest Speakers
John Scarlett, Chairman, President & CEO
Olivia Bloom, EVP, Finance & CFO
Aleksandra Rizo, EVP & CMO
Anil Kapur, EVP, Corporate Strategy & CCO

Market Cap (in millions)
$426 (updated 07/13/2021)

Industry
Biotechnology
Karyopharm Therapeutics Inc.
Session IV
Karyopharm Therapeutics is a commercial-stage pharmaceutical company whose lead drug Xpovio is approved for relapsed/refractory multiple myeloma and DLBCL.

Ticker
KPTI

Guest Speakers
Richard Paulson, President & CEO
Mike Mason, CFO
Jatin Shah, Chief Medical Officer

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$670 (updated 07/20/2021)

Industry
Biotechnology
02:35 PM - 03:05 PM
Envista Holdings Corporation
Session I
Envista is a leading manufacturer of dental consumables and equipment, with a top-three share position across implants, orthodontics, dental imaging, and general consumables.

Ticker
NVST

Guest Speakers
Amir Aghdaei, CEO
Howard Yu, CFO
John Moten, VP, IR

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$6,954 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Asensus Surgical, Inc.
Session II
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking the clinical intelligence to enable consistently superior outcomes and a new standard of surgery.

Ticker
ASXC

Guest Speakers
Anthony Fernando, President & CEO
Shameze Rampertab, EVP & CFO
Mike Vallie, Westwicke Partners
Mark Klausner, Westwicke Partners

Market Cap (in millions)
$665 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Arbutus Biopharma Corporation
Session III
Arbutus Biopharma Corporation is an early-stage biopharma company with hepatitis B virus RNAi drug currently in Phase 1 studies.

Ticker
ABUS

Guest Speakers
William Collier, President & CEO
David Hastings, CFO
Michael McElhaugh, Chief Business Officer
Gaston Picchio, Chief Development Officer
Pam Murphy, IR Consultant

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$282 (updated 07/13/2021)

Industry
Biotechnology
IGM Biosciences, Inc.
Session IV
IGM Biosciences is a Mountain View, CA-based clinical-stage biotechnology company focused on the development of novel, engineered IgM antibodies for the treatment of cancer.

Ticker
IGMS

Guest Speakers
Fred Schwarzer, CEO
Misbah Tahir, CFO

Market Cap (in millions)
$2,545 (updated 07/29/2021)

Industry
Biotechnology
03:10 PM - 03:40 PM
HealthEquity, Inc.
Session II
HealthEquity is a leading HSA administrator.

Ticker
HQY

Guest Speakers
Jon Kessler, President & CEO
Tyson Murdock, EVP & CFO
Richard Putnam, VP, IR

Analyst
Mark S. Marcon, CFA
mmarcon@rwbaird.com
414.298.7556

Market Cap (in millions)
$6,522 (updated 07/13/2021)

Industry
Health Care Providers & Services
AVEO Pharmaceuticals, Inc.
Session III
AVEO Pharmaceuticals, Inc. is a commercial-stage biopharma company, whose lead candidate Fotivda is approved for the treatment of r/r RCC.

Ticker
AVEO

Guest Speakers
Michael Bailey, President & CEO
Erick Lucera, CFO
Mike Ferraresso, CCO

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$205 (updated 07/13/2021)

Industry
Biotechnology
VistaGen Therapeutics, Inc.
Session IV
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Francisco, CA focused on developing PH94B as a treatment for social anxiety disorder.

Ticker
VTGN

Guest Speakers
Shawn Singh, CEO
Mark McPartland, VP, Corporate Development
Mark Flather, VP, IR

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$509 (updated 07/26/2021)

Industry
Biotechnology
Tabula Rasa HealthCare, Inc.
Session I
Tabula Rasa HealthCare (TRHC) is a leading provider of data-driven medication safety and risk management solutions to healthcare organizations.

Ticker
TRHC

Guest Speakers
Calvin Knowlton, Co-Founder, Chairman & CEO
Brian Adams, CFO
Orsula Knowlton, Co-Founder, President, Chief Marketing & New Busin
Kevin Boesen, Chief Sales Officer

Analyst
Vikram Kesavabhotla
vkesavabhotla@rwbaird.com
646.557.2727

Market Cap (in millions)
$1,188 (updated 07/13/2021)

Industry
Health Care Technology
03:45 PM - 04:15 PM
STERIS plc
Session I
STERIS is a leading provider of infection prevention and sterilization solutions to healthcare facilities, medical device manufacturers, and drug companies.

Ticker
STE

Guest Speakers
Dan Carestio, CEO
Julie Winter, VP, IR

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$21,003 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Cue Biopharma, Inc.
Session II
Cue Biopharma, Inc. is an early-stage clinical biopharma company with CUE-101 in HPV16+ HNSCC.

Ticker
CUE

Guest Speakers
Daniel Passeri, CEO
Anish Suri, President & CSO
Kerri-Ann Millar, CFO
George Zavoico, VP, IR & Corporate Development

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$351 (updated 07/13/2021)

Industry
Biotechnology
Celyad Oncology SA
Session III
Celyad Oncology SA is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.

Ticker
CYAD-BE

Guest Speakers
Filippo Petti, CEO
David Gilham, CSO
Charles Morris, CMO
Sara Zelkovic, Director, Communications, IR

Market Cap (in millions)
$70 (updated 07/13/2021)

Industry
Biotechnology
Cassava Sciences, Inc.
Session IV
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

Ticker
SAVA

Guest Speakers
Remi Barbier, President & CEO
Eric Schoen, CFO

Market Cap (in millions)
$4,134 (updated 07/30/2021)

Industry
Pharmaceuticals
04:20 PM - 04:50 PM
Nurix Therapeutics, Inc.
Session I
Nurix Therapeutics, Inc. is a biotechnology company focused on discovering and developing novel, oral, small molecule therapies that modulate protein levels.

Ticker
NRIX

Guest Speakers
Arthur Sands, CEO
Hans van Houte, CFO
Robert Brown, SVP, Clinical Development
Jason Kantor, SVP, Finance & Investment Strategy

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$1,064 (updated 07/13/2021)

Industry
Biotechnology
Twist Bioscience Corporation
Session II
TWST is a synthetic biology company focused on designing synthetic DNA-based products for a broad range of industries.

Ticker
TWST

Guest Speakers
Emily Leproust, CEO
Jim Thorburn, CFO
Angela Bitting, SVP, Corporate Affairs

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$6,241 (updated 07/13/2021)

Industry
Biotechnology
InMode Ltd.
Session III
INMD is a leading provider of innovative, energy-based, minimally-invasive surgical aesthetic and medical treatment solutions for face and body contouring, medical aesthetics, and women�s health.

Ticker
INMD

Guest Speakers
Moshe Mizrahy, CEO
Yair Malca, CFO

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$3,500 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Decibel Therapeutics, Inc.
Session IV
Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine.

Ticker
DBTX

Guest Speakers
Laurence Reid, CEO
Lis Leiderman, CFO

Market Cap (in millions)
$188 (updated 08/09/2021)

Industry
Biotechnology
04:55 PM - 05:25 PM
Arrowhead Pharmaceuticals, Inc.
Session I
Arrowhead Pharmaceuticals, Inc. is a late-stage clinical biopharma company with lead asset JNJ-3989 in the Phase 2b REEF-1 trial in HBV.

Ticker
ARWR

Guest Speakers
Chris Anzalone, CEO
Vince Anzalone, VP, Finance & IR

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$6,565 (updated 07/13/2021)

Industry
Biotechnology
Emergent BioSolutions Inc.
Session II
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats.

Ticker
EBS

Guest Speakers
Rich Lindahl, EVP, CFO
Bob Burrows, VP, IR

Market Cap (in millions)
$3,305 (updated 07/13/2021)

Industry
Biotechnology
Talkspace, Inc.
Session III
Talkspace (TALK) is a provider of virtual psychotherapy and psychiatry solutions direct to consumers, through health plans, and through employer benefit offerings.

Ticker
TALK

Guest Speakers
Oren Frank, CEO
Jennifer Fulk, CFO

Analyst
Vikram Kesavabhotla
vkesavabhotla@rwbaird.com
646.557.2727

Market Cap (in millions)
$1,544 (updated 07/14/2021)

Industry
Health Care Providers & Services
AavantiBio, Inc.*
Session IV
AavantiBio is a preclinical-stage biopharmaceutical company committed to developing and commercializing novel gene transfer and gene editing therapies for the treatment of rare and ultra-rare genetic diseases.

Ticker
PRIVATE

Guest Speakers
Bo Cumbo, President & CEO
Doug Swirsky, CFO

Industry
Biotechnology
05:30 PM - 06:00 PM
Instil Bio, Inc.
Session I
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer.

Ticker
TIL

Guest Speakers
Bronson Crouch, CEO
Steve Laumas, CFO
Zachary Roberts, CMO
Vijay Chiruvolu, CTO
Joshua Johnson, Chief of Staff

Analyst
Jack K. Allen, CFA
jkallen@rwbaird.com
646.557.3205

Industry
Biotechnology
Humanigen, Inc.
Session II
Humanigen, Inc., a clinical stage biopharmaceutical company, develops a portfolio of immuno-oncology and immunology monoclonal antibodies in the United States

Ticker
HGEN

Guest Speakers
TIMOTHY MORRIS, COO/CFO
Ken Trbovich, SVP IR
Cameron Durrant, Chairman, CEO
Adrian Kilcoyne, CMO

Market Cap (in millions)
$933 (updated 08/05/2021)

Industry
Biotechnology
NanoString Technologies, Inc.
Session IV
NanoString develops, manufactures, and sells tools that are used in translational/basic research to unlock biologic information from a variety of sample types.

Ticker
NSTG

Guest Speakers
Brad Gray, President & CEO
Tom Bailey, CFO
Doug Farrell, VP, IR & Corporate Communications

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$2,839 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
FluGen, Inc.*
Session III
FluGen, Inc. is a clinical-stage vaccine company transforming vaccine efficacy in respiratory diseases. The company’s lead candidate is M2SR, a supra-seasonal, live, single-replication, intranasal flu vaccine.

Ticker
PRIVATE

Guest Speakers
Paul Radspinner, Founder, President & CEO
Boyd Clarke, Executive Chairman

Industry
Biotechnology
Presentations for Wednesday, September 15, 2021
07:55 AM - 08:25 AM
Progenity, Inc.
Session I
Progenity, Inc. is a commercial-stage molecular diagnostics company, transitioning into a biotech company focused on GI health and oral biopharmaceuticals.

Ticker
PROG

Guest Speakers
Eric d'Esparbes, Interim CEO

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$101 (updated 08/12/2021)

Industry
Health Care Providers & Services
Lantheus Holdings, Inc.
Session II
Lantheus engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes, and assist clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment operations offers direct distribution in Canada and Puerto Rico; third-party distribution in Europe, Canada, Australia, Asia-Pacific, and Latin America; and EXINI business in Sweden. The company was founded in 1956 and is headquartered in North Billerica, MA.

Ticker
LNTH

Guest Speakers
Mary Anne Heino, President & CEO
Robert Marshall, CFO & Treasurer
Mark Kinarney, Senior Director, Head of IR

Market Cap (in millions)
$1,700 (updated 08/12/2021)

Industry
Health Care Equipment & Supplies
Innovent Biologics, Inc.
Session III
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures and distributes monoclonal antibody injection, protein drugs, and other related products.

Guest Speakers
Ronnie Ede, CFO
Wendy Song, IR Director
Anna Zhu, Senior IR Director

Market Cap (in millions)
$12,753 (updated 07/29/2021)

Industry
Biotechnology
08:30 AM - 09:00 AM
ICON plc
Session I
ICON is a leading Contract Research Organization (CRO), or provider of outsourced R&D services, for pharmaceutical, biotech, medical device companies and government agencies.

Ticker
ICLR

Guest Speakers
Brendan Brennan, CFO
Jonathan Curtain, VP, Corp Finance & IR
Kate Haven, VP, IR

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$11,192 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
Novanta Inc.
Session II
Novanta is a manufacturer of highly engineered specialty components and sub-assembly technologies sold principally into medical device and advanced industrial equipment markets.

Ticker
NOVT

Guest Speakers
Matthijs Glastra, CEO
Robert Buckley, CFO
Ray Nash, VP, Corporate Finance

Analyst
Robert W. Mason, CFA
rmason@rwbaird.com
615.341.7111

Market Cap (in millions)
$4,868 (updated 07/13/2021)

Industry
Electronic Equipment, Instruments & Components
Voyager Therapeutics Inc.
Session III
Voyager is a Massachusetts-based, clinical-stage biotechnology company developing gene therapies for CNS diseases.

Ticker
VYGR

Guest Speakers
Michael Higgins, CEO
Glenn Pierce, CSO
Allison Dorval, CFO

Analyst
Jack K. Allen
jkallen@rwbaird.com
646.557.3205

Market Cap (in millions)
$147 (updated 07/13/2021)

Industry
Biotechnology
GT Biopharma, Inc.
Session IV
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform.

Ticker
GTBP

Guest Speakers
Anthony Cataldo, Chairman & CEO
Dr. Jeffrey Miller, Consulting Chief Scientific Officer
Dr. Gregory Berk, Chief Medical Officer
Michael Handelman, CFO
Gavin Choy, Chief Clinical Development Officer
David Castaneda, IR

Market Cap (in millions)
$172 (updated 08/17/2021)

Industry
Biotechnology
09:05 AM - 09:35 AM
Surface Oncology, Inc.
Session I
Surface Oncology, Inc. is a Cambridge, MA-based clinical-stage biotech company focused on the development of novel, next-generation, targeted immunotherapeutic antibodies for the treatment of cancer.

Ticker
SURF

Guest Speakers
Rob Ross, CEO
Jessica Fees, CFO
Vito Palombella, Chief Scientific Officer
Stephen Jasper, IR

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$313 (updated 07/13/2021)

Industry
Biotechnology
Accolade, Inc.
Session II
Accolade is a leading provider of member navigation solutions, primarily sold to large self-insured employers.

Ticker
ACCD

Guest Speakers
Steve Barnes, CFO
Todd Friedman, SVP, IR

Analyst
Vikram Kesavabhotla
vkesavabhotla@rwbaird.com
646.557.2727

Market Cap (in millions)
$3,603 (updated 07/13/2021)

Industry
Health Care Providers & Services
Cellectis SA
Session III
Cellectis is an early-stage biopharma company with various assets from the UCART platform being tested in Phase 1 trials in various hematologic cancers.

Ticker
CLLS

Guest Speakers
André Choulika, CEO
David Sourdive, EVP Strategic Initiatives
Carrie Brownstein , CMO
Eric Dutang, CFO

Analyst
Jack K. Allen
jkallen@rwbaird.com
646.557.3205

Market Cap (in millions)
$686 (updated 07/13/2021)

Industry
Biotechnology
Immunovant, Inc.
Session IV
Immunovant is a clinical stage biotechnology company developing IMVT-1401, an FcRn inhibitor, in a number of autoimmune diseases.

Ticker
IMVT

Guest Speakers
Pete Salzmann, CEO
Tom Dorney, Director, IR & Strategy

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$978 (updated 07/26/2021)

Industry
Biotechnology
09:40 AM - 10:10 AM
LivaNova Plc
Session I
LivaNova has two platforms: cardiovascular and neuromodulation. Cardiovascular includes heart-lung machines and emergent life support. Neuromodulation includes vagus nerve stimulation for epilepsy.

Ticker
LIVN

Guest Speakers
Damien McDonald, CEO
Alex Shvartsburg, CFO
Matthew Dodds, SVP, Corporate Development
Lindsey Little, Senior Director, IR

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$3,972 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
AptarGroup, Inc.
Session II
AptarGroup, Inc. designs, makes and sells dispensing systems for the fragrance and cosmetics, personal care, pharmaceutical, household product and food industries.

Ticker
ATR

Guest Speakers
Stephan Tanda, President & CEO
Gael Touya, President, Aptar Pharma
Matt DellaMaria, SVP, IR & Communications

Analyst
Ghansham Panjabi, Ph.D.
gpanjabi@rwbaird.com
214.220.3040

Market Cap (in millions)
$9,203 (updated 07/13/2021)

Industry
Containers & Packaging
Bonesupport Holding AB
Session III
BONESUPPORT develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient�s own bone and have the capability of eluting drugs.

Ticker
BONEX-SE

Guest Speakers
Emil Billbaeck, CEO
Hakan Johansson, CFO

Market Cap (in millions)
$580 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Castle Biosciences, Inc.
Session IV
CSTL is a dermatological cancer diagnostics company that uses personalized genomic information to help guide treatment decisions, improving patient outcomes and reducing healthcare costs.

Ticker
CSTL

Guest Speakers
Derek Maetzold, President & CEO
Frank Stokes, CFO
Camilla Zuckero, Executive Director, IR Corporate Communications

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$1,804 (updated 07/13/2021)

Industry
Health Care Providers & Services
10:15 AM - 10:45 AM
Catalent, Inc.
Session I
Catalent is a leading Contract Development and Manufacturing Organization (CDMO), serving the biopharma industry.

Ticker
CTLT

Guest Speakers
Thomas Castellano, CFO
Paul Surdez, VP, IR

Analyst
Evan A. Stover, CFA
estover@rwbaird.com
312.609.5439

Market Cap (in millions)
$19,274 (updated 07/13/2021)

Industry
Pharmaceuticals
Sarepta Therapeutics, Inc.
Session II
Sarepta Therapeutics is focused on the discovery and development of gene therapy and RNA-based therapeutics for serious and life-threatening rare diseases, especially DMD.

Ticker
SRPT

Guest Speakers
Doug Ingram, President & CEO
Ian Estepan, EVP & CFO
Francesca Nolan, Executive Director, IR & Corporate Communications
Mary Jenkins, Senior Manager, IR & Corporate Communications

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$5,842 (updated 07/13/2021)

Industry
Biotechnology
R1 RCM Inc.
Session III
R1 RCM (RCM) is a leading provider of end-to-end revenue cycle management solutions to healthcare systems and physician groups.

Ticker
RCM

Guest Speakers
Joe Flanagan, President & CEO
Rachel Wilson, CFO & Treasurer
Atif Rahim, SVP, IR

Analyst
Vikram Kesavabhotla
vkesavabhotla@rwbaird.com
646.557.2727

Market Cap (in millions)
$5,907 (updated 07/13/2021)

Industry
Health Care Providers & Services
Intra-Cellular Therapies, Inc.
Session IV
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system.

Ticker
ITCI

Guest Speakers
Sharon Mates, CEO
Mark Neumann, Chief Commercial Officer
Juan Sanchez, VP, IR

Market Cap (in millions)
$3,100 (updated 07/26/2021)

Industry
Pharmaceuticals
10:50 AM - 11:20 AM
Nevro Corp.
Session II
Nevro markets an FDA-approved spinal cord stimulation system for the treatment of chronic pain. Original innovation was high-frequency stimulation though programming flexibility has recently increased.

Ticker
NVRO

Guest Speakers
Keith Grossman, Chairman, CEO & President
Rod MacLeod, CFO
Julie Dewey, VP, IR & Corporate Communications

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$5,418 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Neurocrine Biosciences, Inc.
Session III
Neurocrine Biosciences is a biotechnology company focused on the development of therapeutics for neurological and endocrine-based diseases and disorders.

Ticker
NBIX

Guest Speakers
Matthew Abernethy, CFO
Eiry Roberts, CMO

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$9,214 (updated 07/13/2021)

Industry
Biotechnology
Homology Medicines, Inc.
Session IV
Homology Medicines, Inc. is an early-stage clinical biopharma company with adeno-associated virus gene therapy HMI-102 in phenylketonuria.

Ticker
FIXX

Guest Speakers
Albert Seymour, Chief Scientific Officer
Theresa McNeely, Chief Communications Officer & Patient Advocate
Brad Smith, CFO

Analyst
Jack K. Allen
jkallen@rwbaird.com
646.557.3205

Market Cap (in millions)
$290 (updated 07/27/2021)

Industry
Biotechnology
Align Technology, Inc.
Session I
Align Technology is a leading manufacturer in orthodontics with its Invisalign clear aligner system designed as an alternative to traditional orthodontic brackets/wires.

Ticker
ALGN

Guest Speakers
John Morici, CFO
Simon Beard, SVP & MD, Americas
Madelyn Homick, Director, Corporate Communications & IR

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$55,216 (updated 08/09/2021)

Industry
Health Care Equipment & Supplies
11:25 AM - 11:55 AM
AmerisourceBergen Corporation
Session I
ABC is a leading U.S. pharmaceutical distributor, the largest specialty distributor, and a leader in pharmacy support services.

Ticker
ABC

Guest Speakers
Jim Cleary, EVP & CFO
Robert Mauch, EVP & Group President

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$23,709 (updated 07/13/2021)

Industry
Health Care Providers & Services
Genocea Biosciences, Inc.
Session III
Genocea Biosciences is a Cambridge, MA-based biotech company focused on the development of therapies for the treatment of cancer through its proprietary ATLAS neoantigen-discovery platform.

Ticker
GNCA

Guest Speakers
Chip Clark, President & CEO
Diantha Duvall, CFO

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$114 (updated 07/13/2021)

Industry
Biotechnology
Assembly Biosciences, Inc.
Session IV
Assembly is a clinical stage biotechnology company developing curative treatments for chronic hepatitis B, and microbiome-associated diseases.

Ticker
ASMB

Guest Speakers
John McHutchison, CEO & President
Lauren Glaser, SVP, IR & Corp Affairs
Jason Okazaki, COO

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$99 (updated 07/27/2021)

Industry
Biotechnology
1Life Healthcare, Inc.
Session II
1Life Healthcare, Inc. is a leading provider of membership-based primary care and integrated digital health solutions to Employers and Consumers

Ticker
ONEM

Guest Speakers
Amir Dan Rubin, Chair & CEO
Bjorn Thaler, CFO

Analyst
Vikram Kesavabhotla
vkesavabhotla@rwbaird.com
646.557.2727

Market Cap (in millions)
$4,200 (updated 08/05/2021)

Industry
Health Care Providers & Services
12:15 PM - 12:45 PM
Jounce Therapeutics, Inc.
Session II
Jounce Therapeutics, Inc. is a Cambridge, MA-based biotech company developing a robust immuno-oncology pipeline.

Ticker
JNCE

Guest Speakers
Hugh Cole, Chief Business Officer
Kim Drapkin, CFO
Elizabeth Trehu, Chief Medical Officer
Mark Yore, Director, IR

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$327 (updated 07/13/2021)

Industry
Biotechnology
Spine BioPharma*
Session III
Spine BioPharma specializes in non-surgical therapies that will reduce pain, restore function and slow or stop pathological spinal disease progression without the use of opioids. Spine BioPharma's lead candidate, Remedisc�, is a first-in-class, therapeutic for the treatment of degenerative disc disease, offering clinical benefits of pain relief, restoration of function and potential prevention of disease progression.

Ticker
Private

Guest Speakers
Marc Viscogliosi, CEO
Fran Magee, CTO & COO

Industry
Biotechnology
Fate Therapeutics, Inc.
Session IV
Fate Therapeutics, a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide.

Ticker
FATE

Guest Speakers
Edward Dulac, CFO

Market Cap (in millions)
$9,000 (updated 07/16/2021)

Industry
Biotechnology
Exact Sciences Corporation
Session I
Exact Sciences is a molecular diagnostics company first focused on reducing colorectal cancer-related deaths through widespread adoption of a non-invasive, proprietary, stool-based DNA screening assay.

Ticker
EXAS

Guest Speakers
Kevin Conroy, Chairman & CEO
Jeff Elliott, EVP, CFO & COO
Megan Jones, Director, IR

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$20,929 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
12:50 PM - 01:20 PM
Tandem Diabetes Care, Inc.
Session I
TNDM has captured ~23% share of the U.S. insulin pump market given success with its market-leading Control-IQ AID system.

Ticker
TNDM

Guest Speakers
Susan Morrison, EVP & CAO
Leigh Vosseller, EVP & CFO

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$6,294 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Mesa Laboratories, Inc.
Session II
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Canada, Europe and Japan.

Ticker
MLAB

Guest Speakers
Gary Owens, CEO
John Sakys, CFO

Market Cap (in millions)
$1,406 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Arcturus Therapeutics Holdings Inc
Session III
Arcturus Therapeutics, Inc. is an early-stage biopharma company with ARCT-810 in OTC deficiency and ARCT-021 for COVID-19.

Ticker
ARCT

Guest Speakers
Joseph Payne, CEO
Andy Sassine, CFO
Padmanabh Chivukula, COO & Chief Scientific Officer
Neda Safarzadeh, Senior Director, Head of IR
Carlo Tanzi, IR

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$900 (updated 07/13/2021)

Industry
Biotechnology
Cala Health, Inc.*
Session IV
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease.

Ticker
PRIVATE

Guest Speakers
Renee Ryan, CEO

Industry
Health Care Technology
01:25 PM - 01:55 PM
Syneos Health, Inc.
Session I
SYNH is a leading provider of clinical development and commercialization services to the biopharmaceutical and medical device industries.

Ticker
SYNH

Guest Speakers
Alistair Macdonald, CEO
Jason Meggs, CFO
Ronnie Speight, SVP, IR
David Watson, Director, IR

Analyst
Eric W. Coldwell
ecoldwell@rwbaird.com
312.609.5467

Market Cap (in millions)
$9,418 (updated 07/13/2021)

Industry
Life Sciences Tools & Services
Axonics, Inc.
Session II
Axonics sells a sacral neuromodulation system for treatment of overactive bladder, non-obstructive urinary retention, and fecal incontinence. Axonics also sells Bulkamid for stress urinary incontinence.

Ticker
AXNX

Guest Speakers
Raymond Cohen, CEO
Dan Dearen, President & CFO
Neil Bhalodkar, VP, IR

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$2,891 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Spruce Biosciences, Inc.
Session III
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need.

Ticker
SPRB

Guest Speakers
Richard King, CEO
Samir Gharib, CFO
Rosh Dias, Chief Medical Officer

Market Cap (in millions)
$256 (updated 07/13/2021)

Industry
Biotechnology
TrAMPoline Pharma, Inc.*
Session IV
TrAMPoline Pharma is a cellular immunotherapy company that is developing personalized (autologous) therapies for solid tumor cancer.

Ticker
PRIVATE

Guest Speakers
Eduardo Davila, Co-founder & CSO
Douglas Swirsky, Co-Founder & Director

Industry
Biotechnology
02:00 PM - 02:30 PM
Insulet Corporation
Session I
Insulet's Omnipod system is a proprietary tubeless insulin infusion system we estimate accounts for ~27% of the $3B ww insulin pump market.

Ticker
PODD

Guest Speakers
Bret Christensen, EVP, Chief Commercial Officer
Deborah Gordon, VP, IR

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$19,647 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
ORIC Pharmaceuticals, Inc.
Session II
ORIC Pharmaceuticals is a clinical-stage biotech company focused on developing novel therapies to overcoming resistance in cancer.

Ticker
ORIC

Guest Speakers
Jacob Chacko, CEO
Dominic Piscitelli, CFO

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$664 (updated 07/13/2021)

Industry
Biotechnology
Atreca, Inc.
Session III
Atreca is a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibody-target pairs for the treatment of solid tumors.

Ticker
BCEL

Guest Speakers
John Orwin, CEO
Tito Serafini, Chief Strategy Officer
Herb Cross, CFO
Jonathan Benjamin, SVP, Clinical Research
Alex Gray, IR

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$325 (updated 07/13/2021)

Industry
Biotechnology
Eiger BioPharmaceuticals, Inc.
Session IV
Eiger BioPharmaceuticals, Inc. is a late-stage clinical company, with lead combination lonafarnib plus ritonavir in the Phase 3 D-LIVR trial for hepatitis δ virus infection.

Ticker
EIGR

Guest Speakers
David Cory, President & CEO
Sriram Ryali, CFO
Ingrid Choong, SVP, Clinical Development

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$270 (updated 07/22/2021)

Industry
Biotechnology
02:35 PM - 03:05 PM
Myovant Sciences Ltd.
Session I
Myovant is a Switzerland-based biopharmaceutical company that focuses on the acquisition, development and commercialization of novel therapeutics for the treatment of endocrine diseases.

Ticker
MYOV

Guest Speakers
Dave Marek, CEO
Lauren Merendino, Chief Commercial Officer
Juan Camilo Arjona, Chief Medical Officer
Ryan Crowe, VP, IR
Uneek Mehra, Chief Financial & Business Officer

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$2,028 (updated 07/13/2021)

Industry
Biotechnology
Dentsply Sirona Inc.
Session II
DENTSPLY Sirona is a leading manufacturer of dental consumables and equipment across the globe.

Ticker
XRAY

Guest Speakers
Jorge Gomez, EVP & CFO
Andrea Daley, VP, IR

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$13,920 (updated 07/23/2021)

Industry
Health Care Equipment & Supplies
NeuroPace, Inc.
Session III
Based in Mountain View, Calif., NeuroPace was founded to transform the lives of people living with epilepsy, a debilitating neurological disorder affecting approximately 1 in 26 people.

Ticker
NPCE

Guest Speakers
Mike Favet, CEO
Rebecca Kuhn, CFO
Irina Ridley, General Council

Analyst
Mike Polark, CFA
mpolark@rwbaird.com
617.451.4570

Market Cap (in millions)
$543 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Vir Biotechnology, Inc.
Session IV
Vir Biotechnology, Inc. is a late-stage clinical biopharma company with lead asset VIR-7831 in Phase 3 studies for COVID-19

Ticker
VIR

Guest Speakers
Howard Horn, CFO
Bolyn Hubby, Chief Corporate Affairs Officer
Phil Pang, Chief Medical Officer
Heather Armstong, VP, IR

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$4,866 (updated 07/22/2021)

Industry
Biotechnology
03:10 PM - 03:40 PM
Harpoon Therapeutics, Inc.
Session I
Harpoon Therapeutics, Inc. is a South San Francisco, CA-based clinical-stage biotech company focused on developing and commercializing novel T cell engagers.

Ticker
HARP

Guest Speakers
Jerry McMahon, President & CEO
Georgia Erbez, CFO

Analyst
Colleen M. Kusy, CFA
ckusy@rwbaird.com
646.557.3223

Market Cap (in millions)
$443 (updated 07/13/2021)

Industry
Biotechnology
Leap Therapeutics, Inc.
Session II
Leap Therapeutics, Inc. is a clinical-stage biopharma company with DKN-01 (anti-DKK1 antibody) in development in multiple tumors types, including gastric, hepatobiliary, endometrial, and prostate cancers.

Ticker
LPTX

Guest Speakers
Doug Onsi, CEO
Cyndi Sirard, Chief Medical Officer
Luke Anderson, Senior Financial Analyst

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$91 (updated 07/13/2021)

Industry
Biotechnology
T-Cure Biosciences, Inc.*
Session III
T-Cure Bioscience, Inc. is an innovative immuno-oncology company committed to delivering effective and durable cell therapies for the treatment of cancer. The Company focuses on isolating high avidity TCR that can be used to engineer a patient�s T cells to effectively target and destroy solid tumors. The Company maintains a pipeline of TCR under clinical and pre-clinical development targeting HERV-E, KK-LC-1, NY-ESO-1 and other antigens associated with solid tumors of significant unmet medical needs, including kidney cancer, breast cancer, lung cancer, gastric cancer, ovarian cancer, liver cancer, pancreatic cancer, sarcoma, and glioblastoma.

Ticker
Private

Guest Speakers
Gang Zeng, CEO & President
Erika von Euw, Senior Director, Translational Research

Industry
Biotechnology
Hanger, Inc.
Session IV
Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HNGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics with approximately 800 patient care locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions.

Ticker
HNGR

Guest Speakers
Thomas Kiraly, EVP & CFO
Seth Frank, VP, IR

Market Cap (in millions)
$968 (updated 07/13/2021)

Industry
Health Care Providers & Services
03:45 PM - 04:15 PM
Natera, Inc.
Session I
Natera, Inc. is a diagnostics company focused on non- or minimally invasive genetic tests for women's health, transplant, and oncology applications.

Ticker
NTRA

Guest Speakers
Steven Chapman, CEO
Michael Brophy, CFO

Analyst
Catherine R. Schulte
cschulte@rwbaird.com
312.609.5460

Market Cap (in millions)
$10,368 (updated 07/13/2021)

Industry
Biotechnology
Merit Medical Systems, Inc.
Session II
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy.

Ticker
MMSI

Guest Speakers
Fred Lampropoulos, Chairman & CEO
Raul Parra, CFO

Market Cap (in millions)
$3,566 (updated 07/13/2021)

Industry
Health Care Equipment & Supplies
Marinus Pharmaceuticals, Inc.
Session III
Marinus is a clinical stage biopharmaceutical company developing ganaxolone to treat seizures, depression and other neuropsychiatric disorders.

Ticker
MRNS

Guest Speakers
Scott Braunstein, CEO
Steve Pfanstiel, CFO
Sasha Damouni Ellis, VP, Corporate Affairs & IR
Alex Aimetti, VP, Scientific Affairs

Analyst
Brian P. Skorney, CFA
bskorney@rwbaird.com
646.557.3204

Market Cap (in millions)
$687 (updated 07/13/2021)

Industry
Pharmaceuticals
CooperCompanies
Session IV
The Cooper Companies is a specialty medical device manufacturer serving the $9 billion worldwide contact lens (CVI) and $4 billion worldwide women's healthcare (CSI) markets.

Ticker
COO

Guest Speakers
Brian Andrews, EVP, CFO & Treasurer
Kim Duncan, VP, IR & Risk Management

Analyst
Jeff D. Johnson, O.D., CFA
jdjohnson@rwbaird.com
414.298.6027

Market Cap (in millions)
$20,558 (updated 07/29/2021)

Industry
Health Care Equipment & Supplies
04:20 PM - 04:50 PM
Magnolia Medical Technologies, Inc.*
Session I
Magnolia Medical Technologies is a commercial-stage medtech company that develops and commercializes innovative blood and bodily fluid collection devices that significantly improve the accuracy, consistency and predictability of critical laboratory tests. Magnolia’s flagship product line, Steripath, is the only FDA-cleared device platform indicated to reduce blood culture contamination that causes false positive sepsis test results. The company has 19 published peer-reviewed studies and presented data sets demonstrating 74% to 100% sustained reductions in false positives. Magnolia’s clinical results are driving changes to the formal standard of care for sepsis testing accuracy via guideline updates and directives from entities including CLSI and Congress. Additionally, Magnolia has amassed an intellectual property portfolio including more than 80 issued method, apparatus and design patents with more than 50 additional patent applications pending.

Ticker
Private

Guest Speakers
Greg Bullington, CEO & Co-founder
Patrick O'Malley, CFO

Industry
Health Care Equipment & Supplies
Reneo Pharmaceuticals, Inc.
Session III
Reneo is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). Reneo is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. REN001 has been shown to increase transcription of genes involved in mitochondrial function and increase fatty acid oxidation and may increase production of new mitochondria.

Ticker
RPHM

Guest Speakers
Greg Flesher, President & CEO
Vinny Jindal, CFO

Market Cap (in millions)
$209 (updated 07/13/2021)

Industry
Biotechnology
IDEAYA Biosciences, Inc.
Session IV
Ideaya Biosciences, Inc. is an early-stage clinical precision oncology biopharma company focused on developing assets targeting synthetic lethality.

Ticker
IDYA

Guest Speakers
Yujiro Hata, CEO
Paul Stone, CFO

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$614 (updated 07/16/2021)

Industry
Biotechnology
Agenus Inc.
Session II
Agenus Inc., a clinical-stage immuno-oncology company, discovers, manufactures, and develops immuno-oncology products in the United States and internationally.

Ticker
AGEN

Guest Speakers
Jennifer Buell, President & COO
Jan Medina, Director, IR

Market Cap (in millions)
$1,378 (updated 08/16/2021)

Industry
Biotechnology
04:55 PM - 05:25 PM
Cullgen, Inc.*
Session I
Cullgen is a privately held biopharmaceutical company dedicated to the development of first-in-class new chemical entities (NCEs) for the treatment of diseases lacking effective therapeutic approaches.

Ticker
PRIVATE

Guest Speakers
Thomas Eastliing, CFO
Yue Xiong, Chief Science Officer

Industry
Biotechnology
Certara, Inc.
Session III
Certara (CERT) is a provider of biosimulation software and tech-enabled services that support pharma and biotech companies.

Ticker
CERT

Guest Speakers
Andrew Schemick, CFO

Market Cap (in millions)
$4,045 (updated 07/29/2021)

Industry
Health Care Technology
BeyondSpring Inc.
Session IV
Headquartered in New York City, BeyondSpring is a global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes for patients who have high unmet medical needs.

Ticker
BYSI

Guest Speakers
Lan Huang, CEO
Elizabeth Czerepak, CFO
Rich Daly, COO

Analyst
Joel L. Beatty, MD, CFA
jbeatty@rwbaird.com
646.557.2731

Market Cap (in millions)
$364 (updated 08/03/2021)

Industry
Biotechnology
Frontier Medicines Corporation*
Session II
Frontier Medicines is a precision medicine company that has pioneered a proprietary discovery and development platform to develop medicines against disease-causing proteins previously considered undruggable. The company is deploying its groundbreaking scientific approaches in chemoproteomics, covalent drug discovery, and machine learning to develop medicines to treat a number of debilitating diseases, starting with cancer.

Ticker
PRIVATE

Guest Speakers
Chris Varma, Chairman & CEO
Greg Chow, CFO
Kevin Webster, CSO

Industry
Biotechnology

* Denotes private company
For important information on items such as investment ratings, risk ratings, analyst compensation and other issues click here. For specific company disclosures we cover please click here.
Additional information on companies mentioned herein is available upon request.